The latest cash injection means Tayside Flow has raised more than £1.7m in equity and debt funding, in spite of the gloom prevailing in funding markets.
The Dundee-based life science business is developing a new generation of heart implants.
Braveheart Investments yesterday said it had joined forces with Sir Tom Farmer, Scottish Enterprise and merchant bank Quayle Munro to invest more than £500,000 in a further funding round for life science business Tayside Flow Technologies.
The latest cash injection means Tayside Flow has raised more than £1.7m in equity and debt funding, in spite of the gloom prevailing in funding markets.
The Dundee-based life science business is developing a new generation of heart implants.